Quinazolines for PDK1 inhibition

Details for Australian Patent Application No. 2007336893 (hide)

Owner Novartis AG

Inventors Dove, Jeffrey; Subramanian, Sharada; Ramurthy, Savithri; Jain, Rama; Aikawa, Mina; Murray, Jeremy M.; Rico, Alice C.; Lin, Xiaodong; Zhou, Yasheen; Shu, Wei; Warne, Robert L.; Basham, Steven E.; Amiri, Payman; Wang, Xiaojing M.

Agent Davies Collison Cave

Pub. Number AU-A-2007336893

PCT Pub. Number WO2008/079988

Priority 60/876,972 22.12.06 US; 60/999,170 15.10.07 US

Filing date 20 December 2007

Wipo publication date 3 July 2008

International Classifications

C07D 239/84 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61P 35/00 (2006.01) Antineoplastic agents

C07D 401/08 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 403/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 411/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

16 July 2009 PCT application entered the National Phase

  PCT publication WO2008/079988 Priority application(s): WO2008/079988

9 August 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007336897-Macromolecular conjugates of cystic fibrosis transmembrane conductance regulator protein inhibitors and uses thereof

2007336873-4-{4-[({3-tert-Butyl-1-[3-(hydroxymethyl) phenyl]-1H-pyrazol-5-yl } carbamoyl)-amino] -3-fluorophenoxy} - N-methylpyridine-2-carboxamide as well as prodrugs and salts thereof for the treatment of cancer